Liver Transplantation Using Grafts From Donors After Circulatory Death: A Propensity Score–Matched Study From a Single Center

American Journal of Transplantation

Volumn 16, Issue 6, 2016, Pages 1795-1804

  Laing, R W ^a,c   Scalera, I ^a   Isaac, J ^a,b   Mergental, H ^a   Mirza, D F ^a,b   Hodson, J ^a   Wilkin, R J W ^a,c   Perera, M T P R ^a,b   Muiesan, P ^a,b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c University of Birmingham   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; UREA;

ACUTE KIDNEY FAILURE; ADULT; ANASTOMOSIS STENOSIS; ARTERY OCCLUSION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT DISEASE; BILE LEAKAGE; BRAIN DEATH; CADAVER DONOR; CHOLANGITIS; CHOLESTASIS; CIRCULATORY DEATH; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATIC ARTERY; HEPATIC ARTERY THROMBOSIS; HUMAN; ISCHEMIA; ISCHEMIC CHOLANGIOPATHY; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT SELECTION; POST TREATMENT SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPENSITY SCORE; UREA BLOOD LEVEL;

EID: 84978893093     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13699     Document Type: Article

References (49)

1. Office for National Statistics. 2008 [cited 2015 Nov]. Office for National Statistics: Health Service Quarterly. Available from: www.ons.gov.uk
2. Johnson RJ, Bradbury LL, Martin K, Neuberger J, Registry UKT. Organ donation and transplantation in the UK-the last decade: A report from the UK national transplant registry. Transplantation 2014; 97(Suppl 1): S1–S27.
3. NHSBT. Activity report 2014/15. [cited 2015 Nov]. Available from: http://www.odt.nhs.uk/uk-transplant-registry/annual-activity-report/
4. A definition of irreversible coma. Report of the ad hoc Committee of the harvard medical school to examine the definition of brain death. JAMA 1968; 205: 337–340.
5. Weber M, Dindo D, Demartines N, Ambuhl PM, Clavien PA. Kidney transplantation from donors without a heartbeat. N Engl J Med 2002; 347: 248–255.
6. Kootstra G, Daemen JH, Oomen AP. Categories of non-heart-beating donors. Transplant Proc 1995; 27: 2893–2894.
7. Muiesan P. Non-heart-beating donors: Is it just a matter of control? Transplantation 2003; 76: 1012–1014.
8. Menger MD, Pelikan S, Steiner D, Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: Significance of “reflow paradox.” Am J Physiol 1992; 263(6 Pt 2): H1901–H1906.
9. Pan X, Apinyachon W, Xia W, et al. Perioperative complications in liver transplantation using donation after cardiac death grafts: A propensity-matched study. Liver Transpl 2014; 20: 823–830.
10. Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg 2004; 239: 87–92.
11. Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: An analysis of OPTN/UNOS data. Am J Transplant 2006; 6: 791–796.
12. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006; 82: 1683–1688.
13. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: A meta-analysis. Ann Surg 2011; 253: 259–264.
14. Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: An analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011; 253: 817–825.
15. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: An increased incidence of biliary complications. Transplantation 2003; 75: 1659–1663.
16. Mourad MM, Algarni A, Liossis C, Bramhall SR. Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol 2014; 20: 6159–6169.
17. Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant 2012; 12: 965–975.
18. Jay CL, Lyuksemburg V, Kang R, et al. The increased costs of donation after cardiac death liver transplantation: Caveat emptor. Ann Surg 2010; 251: 743–748.
19. de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: Long-term follow-up from a single center. Am J Transplant 2009; 9: 773–781.
20. Chan EY, Olson LC, Kisthard JA, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2008; 14: 604–610.
21. Axelrod DA, Dzebisashvilli N, Lentine KL, et al. National assessment of early biliary complications after liver transplantation: Economic implications. Transplantation 2014; 98: 1226–1235.
22. NHSBT. Organ Donation and Transplantation Activity Report 2013/14. NHSBT Activity Report; 2014.
23. O'Neill S, Roebuck A, Khoo E, Wigmore SJ, Harrison EM. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int 2014; 27: 1159–1174.
24. Pirenne J, Van Gelder F, Coosemans W, et al. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation. Liver Transpl 2001; 7: 540–545.
25. Moench C, Moench K, Lohse AW, Thies J, Otto G. Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl 2003; 9: 285–289.
26. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265–2281.
27. Working Party of The British Transplantation Society. 2013 [cited 2015 Nov]. Transplantation from donors after deceased circulatory death. Available from: http://www.bts.org.uk/
28. Weitzen S, Lapane KL, Toledano AY, Hume AL, Mor V. Principles for modeling propensity scores in medical research: A systematic literature review. Pharmacoepidemiol Drug Saf 2004; 13: 841–853.
29. Rassen JA, Shelat AA, Myers J, Glynn RJ, Rothman KJ, Schneeweiss S. One-to-many propensity score matching in cohort studies. Pharmacoepidemiol Drug Saf 2012; 21(Suppl 2): 69–80.
30. Austin PC. Statistical criteria for selecting the optimal number of untreated subjects matched to each treated subject when using many-to-one matching on the propensity score. Am J Epidemiol 2010; 172: 1092–1097.
31. Dubbeld J, Hoekstra H, Farid W, et al. Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg 2010; 97: 744–753.
32. Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single-center experience. Liver Transpl 2009; 15: 1028–1035.
33. Callaghan CJ, Charman SC, Muiesan P, et al. Outcomes of transplantation of livers from donation after circulatory death donors in the UK: A cohort study. BMJ Open 2013; 3: e003287.
34. Leithead JA, Armstrong MJ, Corbett C, et al. Hepatic ischemia reperfusion injury is associated with acute kidney injury following donation after brain death liver transplantation. Transpl Int 2013; 26: 1116–1125.
35. Gaffey MJ, Boyd JC, Traweek ST, et al. Predictive value of intraoperative biopsies and liver function tests for preservation injury in orthotopic liver transplantation. Hepatology 1997; 25: 184–189.
36. DeOliveira ML, Jassem W, Valente R, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: Results from a matched control study in a single large volume center. Ann Surg 2011; 254: 716–722.
37. Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: The untold story. Surgery 2009; 146: 543–552; discussion 552-543.
38. Taner CB, Bulatao IG, Willingham DL, et al. Events in procurement as risk factors for ischemic cholangiopathy in liver transplantation using donation after cardiac death donors. Liver Transpl 2012; 18: 100–111.
39. Oniscu GC, Randle LV, Muiesan P, et al. In situ normothermic regional perfusion for controlled donation after circulatory death–the United Kingdom experience. Am J Transplant 2014; 14: 2846–2854.
40. Vogel T, Brockmann JG, Coussios C, Friend PJ. The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury. Transplant Rev (Orlando) 2012; 26: 156–162.
41. Sutton ME, op den Dries S, Karimian N, et al. Criteria for viability assessment of discarded human donor livers during ex vivo normothermic machine perfusion. PLoS One 2014; 9: e110642.
42. Perera M, Mergental H, Stephenson B, et al. First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion. Liver Transpl 2016; 22: 120–124.
43. Obermajer N, Popp FC, Johnson CL, Benseler V, Dahlke MH. Rationale and prospects of mesenchymal stem cell therapy for liver transplantation. Curr Opin Organ Transplant 2014; 19: 60–64.
44. Van Raemdonck D, Neyrinck A, Rega F, Devos T, Pirenne J. Machine perfusion in organ transplantation: A tool for ex-vivo graft conditioning with mesenchymal stem cells? Curr Opin Organ Transplant 2013; 18: 24–33.
45. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783–790.
46. Dutkowski P, Oberkofler CE, Slankamenac K, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg 2011; 254: 745–753; discussion 753.
47. Scalera I, Angelico R, Iqbal A, et al. Artery-first reperfusion of liver grafts from donors after cardiac death (dcd): Hemodynamic profile and post-operative outcome. In ILTS, Chicago, USA, 2015: Queen Elizabeth Hospital, Birmingham, United Kingdom, 2015.
48. Vendrell M, Hessheimer AJ, Ruiz A, et al. Coagulation profiles of unexpected DCDD donors do not indicate a role for exogenous fibrinolysis. Am J Transplant 2015; 15: 764–771.
49. Simon TC, Verhoeven CJ, de Jonge J, et al. Liver grafts procured from donors after circulatory death have no increased risk for microthrombi formation. In ILTS, Chicago, USA, 2015: Erasmus MC, University Medical Center Rotterdam, 2015.